BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32086945)

  • 1. Elevated Fructose and Uric Acid Through Aldose Reductase Contribute to Experimental and Human Alcoholic Liver Disease.
    Wang M; Chen WY; Zhang J; Gobejishvili L; Barve SS; McClain CJ; Joshi-Barve S
    Hepatology; 2020 Nov; 72(5):1617-1637. PubMed ID: 32086945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats.
    Sanchez-Lozada LG; Andres-Hernando A; Garcia-Arroyo FE; Cicerchi C; Li N; Kuwabara M; Roncal-Jimenez CA; Johnson RJ; Lanaspa MA
    J Biol Chem; 2019 Mar; 294(11):4272-4281. PubMed ID: 30651350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of aldose reductase ameliorates alcoholic liver disease by activating AMPK and modulating oxidative stress and inflammatory cytokines.
    Shi C; Wang Y; Gao J; Chen S; Zhao X; Cai C; Guo C; Qiu L
    Mol Med Rep; 2017 Sep; 16(3):2767-2772. PubMed ID: 28677809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldose reductase inhibitor protects mice from alcoholic steatosis by repressing saturated fatty acid biosynthesis.
    Guo C; Chen L; Huang J; Wang Y; Shi C; Gao J; Hong Y; Chen T; Qiu L
    Chem Biol Interact; 2018 May; 287():41-48. PubMed ID: 29630881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading.
    Fernandez A; Matias N; Fucho R; Ribas V; Von Montfort C; Nuño N; Baulies A; Martinez L; Tarrats N; Mari M; Colell A; Morales A; Dubuquoy L; Mathurin P; Bataller R; Caballeria J; Elena M; Balsinde J; Kaplowitz N; Garcia-Ruiz C; Fernandez-Checa JC
    J Hepatol; 2013 Oct; 59(4):805-13. PubMed ID: 23707365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice.
    Kim HG; Huang M; Xin Y; Zhang Y; Zhang X; Wang G; Liu S; Wan J; Ahmadi AR; Sun Z; Liangpunsakul S; Xiong X; Dong XC
    J Hepatol; 2019 Nov; 71(5):960-969. PubMed ID: 31295533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acrolein Is a Pathogenic Mediator of Alcoholic Liver Disease and the Scavenger Hydralazine Is Protective in Mice.
    Chen WY; Zhang J; Ghare S; Barve S; McClain C; Joshi-Barve S
    Cell Mol Gastroenterol Hepatol; 2016 Sep; 2(5):685-700. PubMed ID: 28119953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological inhibition of the Src homology phosphatase 2 confers partial protection in a mouse model of alcohol-associated liver disease.
    Hsu MF; Koike S; Chen CS; Najjar SM; Meng TC; Haj FG
    Biomed Pharmacother; 2024 Jun; 175():116590. PubMed ID: 38653109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease.
    Mello A; Hsu MF; Koike S; Chu B; Cheng J; Yang J; Morisseau C; Torok NJ; Hammock BD; Haj FG
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):815-830. PubMed ID: 33068774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase 4 Inhibition as a Therapeutic Target for Alcoholic Liver Disease: From Bedside to Bench.
    Rodriguez WE; Wahlang B; Wang Y; Zhang J; Vadhanam MV; Joshi-Barve S; Bauer P; Cannon R; Ahmadi AR; Sun Z; Cameron A; Barve S; Maldonado C; McClain C; Gobejishvili L
    Hepatology; 2019 Dec; 70(6):1958-1971. PubMed ID: 31081957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the aldose reductase inhibitor fidarestat on ischemia-reperfusion injury in rat retina.
    Obrosova IG; Maksimchyk Y; Pacher P; Agardh E; Smith ML; El-Remessy AB; Agardh CD
    Int J Mol Med; 2010 Jul; 26(1):135-42. PubMed ID: 20514433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty Acids Inhibit LAMP2-Mediated Autophagy Flux via Activating ER Stress Pathway in Alcohol-Related Liver Disease.
    Guo W; Zhong W; Hao L; Dong H; Sun X; Yue R; Li T; Zhou Z
    Cell Mol Gastroenterol Hepatol; 2021; 12(5):1599-1615. PubMed ID: 34284164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose of chronic ethanol exposure in adult zebrafish induces hepatic steatosis and injury.
    Park KH; Kim SH
    Biomed Pharmacother; 2019 Sep; 117():109179. PubMed ID: 31387182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking Dysregulated AMPK Signaling and ER Stress in Ethanol-Induced Liver Injury in Hepatic Alcohol Dehydrogenase Deficient Deer Mice.
    Srinivasan MP; Bhopale KK; Amer SM; Wan J; Kaphalia L; Ansari GS; Kaphalia BS
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31581705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirtuin 6 ameliorates alcohol-induced liver injury by reducing endoplasmic reticulum stress in mice.
    Xin Y; Xu L; Zhang X; Yang C; Wang Q; Xiong X
    Biochem Biophys Res Commun; 2021 Mar; 544():44-51. PubMed ID: 33516881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease.
    Qiu LX; Chen T
    World J Gastroenterol; 2015 Jan; 21(4):1099-107. PubMed ID: 25632182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological activation of aldehyde dehydrogenase 2 by Alda-1 reverses alcohol-induced hepatic steatosis and cell death in mice.
    Zhong W; Zhang W; Li Q; Xie G; Sun Q; Sun X; Tan X; Sun X; Jia W; Zhou Z
    J Hepatol; 2015 Jun; 62(6):1375-81. PubMed ID: 25543082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Fisetin Supplementation Protects Against Alcohol-Induced Liver Injury in Mice.
    Sun Q; Zhang W; Zhong W; Sun X; Zhou Z
    Alcohol Clin Exp Res; 2016 Oct; 40(10):2076-2084. PubMed ID: 27575873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathelicidin-related antimicrobial peptide alleviates alcoholic liver disease through inhibiting inflammasome activation.
    Li F; Zhao C; Shao T; Liu Y; Gu Z; Jiang M; Li H; Zhang L; Gillevet PM; Puri P; Deng ZB; Chen SY; Barve S; Gobejishvili L; Vatsalya V; McClain CJ; Feng W
    J Pathol; 2020 Dec; 252(4):371-383. PubMed ID: 33245573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.